Sector
PharmaceuticalsOpen
₹151Prev. Close
₹153.15Turnover(Lac.)
₹873.76Day's High
₹155.08Day's Low
₹147.7352 Week's High
₹240.752 Week's Low
₹92.05Book Value
₹43.91Face Value
₹2Mkt Cap (₹ Cr.)
3,821.61P/E
207.09EPS
0.74Divi. Yield
027 Aug 2024
12:00 AM
AGM
Announcement Date: 27 Aug, 2024
4 Feb 2025
12:00 AM
Board Meeting
Agenda : Audited Result
Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 49.89 | 49.89 | 58.81 | 49.67 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,037.34 | 1,008.48 | 982.28 | 979.84 |
Net Worth | 1,087.23 | 1,058.37 | 1,041.09 | 1,029.51 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 265.45 | 227.33 | 106 | 90.71 |
yoy growth (%) | 16.77 | 114.45 | 16.85 | -77.01 |
Raw materials | -108.86 | -113.04 | -79.37 | -72.52 |
As % of sales | 41.01 | 49.72 | 74.87 | 79.94 |
Employee costs | -22.41 | -17.09 | -11.85 | -17.9 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 43.44 | 22.81 | 1.82 | -15.16 |
Depreciation | -9.12 | -8.95 | -3.66 | -3.25 |
Tax paid | -8.77 | -1.47 | -2.86 | 0 |
Working capital | 33.97 | -80.01 | -110.8 | 56.46 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.77 | 114.45 | 16.85 | -77.01 |
Op profit growth | 58.69 | -220.94 | -39.83 | -186.01 |
EBIT growth | 65.64 | 1,156.67 | -115.03 | -154.81 |
Net profit growth | 50.47 | -94.74 | -33,86,825 | -100.11 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 1,369.73 | 1,420.91 | 1,412.82 | 1,361.62 | 1,179.24 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,369.73 | 1,420.91 | 1,412.82 | 1,361.62 | 1,179.24 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 10.96 | 6.39 | 10.85 | 8.36 | 10.09 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,819.1 | 138.52 | 4,36,379.05 | 1,181.05 | 0.74 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,161 | 78.83 | 1,63,419.8 | 594 | 0.49 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,511.4 | 26.21 | 1,22,010.24 | 1,438.15 | 0.86 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,270.1 | 60.65 | 1,10,629.46 | 485 | 0.86 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,368.7 | 50.5 | 97,653.21 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec. & Independent Dir.
Kausalya Santhanam
Joint Managing Director
Sharat Narasapur
Non-Exec & Non-Independent Dir
Neeraj Bharadwaj
Non-Exec & Non-Independent Dir
Gregory John Andrews
Non-Exec & Non-Independent Dir
Fabian Kausche
Chairman & Independent Directo
Kamal K Sharma
Non-Exec. & Independent Dir.
Milind Sarwate
Managing Director & CEO
N Rajaram
Non Executive Director
Hari Babu Bodepudi
Company Sec. & Compli. Officer
PHILLIP TROTT
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Sequent Scientific Ltd
Summary
Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.
Read More
What is the Sequent Scientific Ltd share price today?
The Sequent Scientific Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹152.68 today.
What is the Market Cap of Sequent Scientific Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sequent Scientific Ltd is ₹3821.61 Cr. as of 07 May ‘25
What is the PE and PB ratio of Sequent Scientific Ltd?
The PE and PB ratios of Sequent Scientific Ltd is 207.09 and 3.46 as of 07 May ‘25
What is the 52 Week High and Low of Sequent Scientific Ltd?
The 52-week high/low is the highest and lowest price at which a Sequent Scientific Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sequent Scientific Ltd is ₹92.05 and ₹240.7 as of 07 May ‘25
What is the CAGR of Sequent Scientific Ltd?
Sequent Scientific Ltd's CAGR for 5 Years at 12.83%, 3 Years at 6.16%, 1 Year at 29.24%, 6 Month at -30.90%, 3 Month at -6.05% and 1 Month at 20.90%.
What is the shareholding pattern of Sequent Scientific Ltd?
The shareholding pattern of Sequent Scientific Ltd is as follows:
Promoters - 52.61 %
Institutions - 18.87 %
Public - 28.36 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
